MGAT1 and neoplasm: While previous work has demonstrated that MUTZ-3 DCs successfully can be loaded with antigens and used to prime tumor-specific cytotoxic T cells (28), antigen-specific T cell activation assays and antigen uptake assays will be important to fully evaluate the potential of MGAT1 KO DCs in the context of antigen processing and presentation.